Deciphering protective immunity against tuberculosis: implications for vaccine development
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Deciphering protective immunity against tuberculosis: implications for vaccine development
Authors
Keywords
-
Journal
Expert Review of Vaccines
Volume -, Issue -, Pages 1-12
Publisher
Informa UK Limited
Online
2019-02-22
DOI
10.1080/14760584.2019.1585246
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- B Cells Producing Type I IFN Modulate Macrophage Polarization in Tuberculosis
- (2018) Alan Bénard et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- BCG Educates Hematopoietic Stem Cells to Generate Protective Innate Immunity against Tuberculosis
- (2018) Eva Kaufmann et al. CELL
- Mycobacterial growth inhibition is associated with trained innate immunity
- (2018) Simone A. Joosten et al. JOURNAL OF CLINICAL INVESTIGATION
- Progression from latent infection to active disease in dynamic tuberculosis transmission models: a systematic review of the validity of modelling assumptions
- (2018) Nicolas A Menzies et al. LANCET INFECTIOUS DISEASES
- Prevention of tuberculosis in rhesus macaques by a cytomegalovirus-based vaccine
- (2018) Scott G Hansen et al. NATURE MEDICINE
- Ecology and evolution of Mycobacterium tuberculosis
- (2018) Sebastien Gagneux NATURE REVIEWS MICROBIOLOGY
- Prevention of M. tuberculosis Infection with H4:IC31 Vaccine or BCG Revaccination
- (2018) Elisa Nemes et al. NEW ENGLAND JOURNAL OF MEDICINE
- PLGA particulate subunit tuberculosis vaccines promote humoral and Th17 responses but do not enhance control of Mycobacterium tuberculosis infection
- (2018) Anneliese S. Ashhurst et al. PLoS One
- New Tuberculosis Vaccine Strategies: Taking Aim at Un-Natural Immunity
- (2018) Mangalakumari Jeyanathan et al. TRENDS IN IMMUNOLOGY
- Mycobacterium tuberculosis-specific CD4+ and CD8+ T cells differ in their capacity to recognize infected macrophages
- (2018) Jason D. Yang et al. PLoS Pathogens
- Safety and immunogenicity of the novel tuberculosis vaccine ID93 + GLA-SE in BCG-vaccinated healthy adults in South Africa: a randomised, double-blind, placebo-controlled phase 1 trial
- (2018) Adam Penn-Nicholson et al. Lancet Respiratory Medicine
- The TLR-4 agonist adjuvant, GLA-SE, improves magnitude and quality of immune responses elicited by the ID93 tuberculosis vaccine: first-in-human trial
- (2018) Rhea N. Coler et al. npj Vaccines
- Pulmonary immunization with a recombinant influenza A virus vaccine induces lung-resident CD4+ memory T cells that are associated with protection against tuberculosis
- (2018) Manuela Flórido et al. Mucosal Immunology
- Phase 2b Controlled Trial of M72/AS01E Vaccine to Prevent Tuberculosis
- (2018) Olivier Van Der Meeren et al. NEW ENGLAND JOURNAL OF MEDICINE
- Novel approaches to tuberculosis vaccine development
- (2017) Stefan H.E. Kaufmann et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Typhoid vaccine development with a human challenge model
- (2017) Nicholas A Feasey et al. LANCET
- Latently and uninfected healthcare workers exposed to TB make protective antibodies againstMycobacterium tuberculosis
- (2017) Hao Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Variable BCG efficacy in rhesus populations: Pulmonary BCG provides protection where standard intra-dermal vaccination fails
- (2017) Frank A.W. Verreck et al. TUBERCULOSIS
- H1:IC31 vaccination is safe and induces long-lived TNF-α+IL-2+CD4 T cell responses in M. tuberculosis infected and uninfected adolescents: A randomized trial
- (2017) Helen Mearns et al. VACCINE
- Safety and immunogenicity of the novel H4:IC31 tuberculosis vaccine candidate in BCG-vaccinated adults: Two phase I dose escalation trials
- (2017) Maria Norrby et al. VACCINE
- Th1 Differentiation Drives the Accumulation of Intravascular, Non-protective CD4 T Cells during Tuberculosis
- (2017) Michelle A. Sallin et al. Cell Reports
- Enhanced control of Mycobacterium tuberculosis extrapulmonary dissemination in mice by an arabinomannan-protein conjugate vaccine
- (2017) Rafael Prados-Rosales et al. PLoS Pathogens
- The Recombinant Bacille Calmette–Guérin Vaccine VPM1002: Ready for Clinical Efficacy Testing
- (2017) Natalie E. Nieuwenhuizen et al. Frontiers in Immunology
- Polyfunctional CD4+ T Cells As Targets for Tuberculosis Vaccination
- (2017) Deborah A. Lewinsohn et al. Frontiers in Immunology
- TBVAC2020: Advancing Tuberculosis Vaccines from Discovery to Clinical Development
- (2017) Stefan H. E. Kaufmann et al. Frontiers in Immunology
- Comprehensive definition of human immunodominant CD8 antigens in tuberculosis
- (2017) Deborah A. Lewinsohn et al. npj Vaccines
- Review of efficacy trials of HIV-1/AIDS vaccines and regulatory lessons learned
- (2016) Rebecca L. Sheets et al. BIOLOGICALS
- A Functional Role for Antibodies in Tuberculosis
- (2016) Lenette L. Lu et al. CELL
- Safety and Immunogenicity of the Recombinant Mycobacterium bovis BCG Vaccine VPM1002 in HIV-Unexposed Newborn Infants in South Africa
- (2016) André G. Loxton et al. Clinical and Vaccine Immunology
- Human isotype‐dependent inhibitory antibody responses against Mycobacterium tuberculosis
- (2016) Natalie Zimmermann et al. EMBO Molecular Medicine
- Human biomarkers: can they help us to develop a new tuberculosis vaccine?
- (2016) Helen A Fletcher et al. Future Microbiology
- IL-17+ CD8+ T cells: Differentiation, phenotype and role in inflammatory disease
- (2016) Ushani Srenathan et al. IMMUNOLOGY LETTERS
- A Subset of Protective γ9δ2T Cells Is Activated by Novel Mycobacterial Glycolipid Components
- (2016) Mei Xia et al. INFECTION AND IMMUNITY
- Effects of B Cell Depletion on Early Mycobacterium tuberculosis Infection in Cynomolgus Macaques
- (2016) Jiayao Phuah et al. INFECTION AND IMMUNITY
- Nonspecific effect of BCG vaccination at birth on early childhood infections: a randomized, clinical multicenter trial
- (2016) Jesper Kjærgaard et al. PEDIATRIC RESEARCH
- Trained immunity: A program of innate immune memory in health and disease
- (2016) M. G. Netea et al. SCIENCE
- Mucosal BCG Vaccination Induces Protective Lung-Resident Memory T Cell Populations against Tuberculosis
- (2016) Carolina Perdomo et al. mBio
- T-cell activation is an immune correlate of risk in BCG vaccinated infants
- (2016) Helen A. Fletcher et al. Nature Communications
- Patients with Tuberculosis Have a Dysfunctional Circulating B-Cell Compartment, Which Normalizes following Successful Treatment
- (2016) Simone A. Joosten et al. PLoS Pathogens
- Targeting Innate-Like T Cells in Tuberculosis
- (2016) Shouxiong Huang Frontiers in Immunology
- Evaluation of the Immunogenicity of Mycobacterium bovis BCG Delivered by Aerosol to the Lungs of Macaques
- (2015) A. D. White et al. Clinical and Vaccine Immunology
- CD1 and mycobacterial lipids activate human T cells
- (2015) Ildiko Van Rhijn et al. IMMUNOLOGICAL REVIEWS
- Tuberculosis vaccines: barriers and prospects on the quest for a transformative tool
- (2015) Christopher L. Karp et al. IMMUNOLOGICAL REVIEWS
- Pulmonary but Not Subcutaneous Delivery of BCG Vaccine Confers Protection to Tuberculosis-Susceptible Mice by an Interleukin 17–Dependent Mechanism
- (2015) Nacho Aguilo et al. JOURNAL OF INFECTIOUS DISEASES
- Challenge accepted: Human challenge trials for dengue
- (2015) Wudan Yan NATURE MEDICINE
- CD8 T cells and Mycobacterium tuberculosis infection
- (2015) Philana Ling Lin et al. Seminars in Immunopathology
- Mouse models of human TB pathology: roles in the analysis of necrosis and the development of host-directed therapies
- (2015) Igor Kramnik et al. Seminars in Immunopathology
- First-in-human trial of the post-exposure tuberculosis vaccine H56:IC31 in Mycobacterium tuberculosis infected and non-infected healthy adults
- (2015) Angelique Kany Kany Luabeya et al. VACCINE
- Improvement of BCG protective efficacy with a novel chimpanzee adenovirus and a modified vaccinia Ankara virus both expressing Ag85A
- (2015) E. Stylianou et al. VACCINE
- The tuberculosis vaccine H4:IC31 is safe and induces a persistent polyfunctional CD4 T cell response in South African adults: A randomized controlled trial
- (2015) Hennie Geldenhuys et al. VACCINE
- Mucosal vaccination with attenuated Mycobacterium tuberculosis induces strong central memory responses and protects against tuberculosis
- (2015) Deepak Kaushal et al. Nature Communications
- Safety, immunogenicity, and efficacy of the candidate tuberculosis vaccine MVA85A in healthy adults infected with HIV-1: a randomised, placebo-controlled, phase 2 trial
- (2015) Birahim Pierre Ndiaye et al. Lancet Respiratory Medicine
- Safety of human immunisation with a live-attenuated Mycobacterium tuberculosis vaccine: a randomised, double-blind, controlled phase I trial
- (2015) François Spertini et al. Lancet Respiratory Medicine
- AdHu5Ag85A Respiratory Mucosal Boost Immunization Enhances Protection against Pulmonary Tuberculosis in BCG-Primed Non-Human Primates
- (2015) Mangalakumari Jeyanathan et al. PLoS One
- Epitope-specific CD4+, but not CD8+, T-cell responses induced by recombinant influenza A viruses protect againstMycobacterium tuberculosisinfection
- (2014) Manuela Flórido et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- High-frequency vaccine-induced CD8+T cells specific for an epitope naturally processed during infection withMycobacterium tuberculosisdo not confer protection
- (2014) Thomas Lindenstrøm et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Advancing Treatment Options for Influenza: Challenges With the Human Influenza Challenge
- (2014) Alicia M. Fry et al. JOURNAL OF INFECTIOUS DISEASES
- Safety and immunogenicity of a candidate tuberculosis vaccine MVA85A delivered by aerosol in BCG-vaccinated healthy adults: a phase 1, double-blind, randomised controlled trial
- (2014) Iman Satti et al. LANCET INFECTIOUS DISEASES
- Assessment of the novel T-cell activation marker–tuberculosis assay for diagnosis of active tuberculosis in children: a prospective proof-of-concept study
- (2014) Damien Portevin et al. LANCET INFECTIOUS DISEASES
- Impact and cost-effectiveness of new tuberculosis vaccines in low- and middle-income countries
- (2014) G. M. Knight et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The role of B cells and humoral immunity in Mycobacterium tuberculosis infection
- (2014) John Chan et al. SEMINARS IN IMMUNOLOGY
- Safety and immunogenicity of the M72/AS01 candidate tuberculosis vaccine when given as a booster to BCG in Gambian infants: An open-label randomized controlled trial
- (2014) Olubukola T. Idoko et al. TUBERCULOSIS
- A novel liposomal adjuvant system, CAF01, promotes long-lived Mycobacterium tuberculosis-specific T-cell responses in human
- (2014) Jaap T. van Dissel et al. VACCINE
- Effect of BCG vaccination against Mycobacterium tuberculosis infection in children: systematic review and meta-analysis
- (2014) A. Roy et al. BMJ-British Medical Journal
- Protection by BCG Vaccine Against Tuberculosis: A Systematic Review of Randomized Controlled Trials
- (2013) Punam Mangtani et al. CLINICAL INFECTIOUS DISEASES
- Antigen-loaded MR1 tetramers define T cell receptor heterogeneity in mucosal-associated invariant T cells
- (2013) Rangsima Reantragoon et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Control of Chronic Mycobacterium tuberculosis Infection by CD4 KLRG1- IL-2-Secreting Central Memory Cells
- (2013) T. Lindenstrom et al. JOURNAL OF IMMUNOLOGY
- Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial
- (2013) Michele D Tameris et al. LANCET
- Epidemiology: A mortal foe
- (2013) Tom Paulson NATURE
- Out-of-Africa migration and Neolithic coexpansion of Mycobacterium tuberculosis with modern humans
- (2013) Iñaki Comas et al. NATURE GENETICS
- A genetic strategy to identify targets for the development of drugs that prevent bacterial persistence
- (2013) J.-H. Kim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Human Type 5 Adenovirus-Based Tuberculosis Vaccine Induces Robust T Cell Responses in Humans Despite Preexisting Anti-Adenovirus Immunity
- (2013) F. Smaill et al. Science Translational Medicine
- Lessons learnt from the first efficacy trial of a new infant tuberculosis vaccine since BCG
- (2013) Michele Tameris et al. TUBERCULOSIS
- A review of preclinical animal models utilised for TB vaccine evaluation in the context of recent human efficacy data
- (2013) Helen McShane et al. TUBERCULOSIS
- Safety and immunogenicity of the recombinant BCG vaccine VPM1002 in a phase 1 open-label randomized clinical trial
- (2013) Leander Grode et al. VACCINE
- Activated B Cells in the Granulomas of Nonhuman Primates Infected with Mycobacterium tuberculosis
- (2012) Jia Yao Phuah et al. AMERICAN JOURNAL OF PATHOLOGY
- A Human Challenge Model for Mycobacterium tuberculosis Using Mycobacterium bovis Bacille Calmette-Guérin
- (2012) Angela M. Minassian et al. JOURNAL OF INFECTIOUS DISEASES
- The Influence of Bacille Calmette-Guérin Vaccine Strain on the Immune Response against Tuberculosis
- (2011) Nicole Ritz et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Trained Immunity: A Memory for Innate Host Defense
- (2011) Mihai G. Netea et al. Cell Host & Microbe
- CD1b tetramers bind αβ T cell receptors to identify a mycobacterial glycolipid-reactive T cell repertoire in humans
- (2011) Anne G. Kasmar et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The BCG World Atlas: A Database of Global BCG Vaccination Policies and Practices
- (2011) Alice Zwerling et al. PLOS MEDICINE
- Prevention of tuberculosis in Bacille Calmette–Guérin-primed, HIV-infected adults boosted with an inactivated whole-cell mycobacterial vaccine
- (2010) Charles F von Reyn et al. AIDS
- Specific T Cell Frequency and Cytokine Expression Profile Do Not Correlate with Protection against Tuberculosis after Bacillus Calmette-Guérin Vaccination of Newborns
- (2010) Benjamin M. N. Kagina et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Risk factors for severe infections in patients with rheumatoid arthritis treated with rituximab in the autoimmunity and rituximab registry
- (2010) J.-E. Gottenberg et al. ARTHRITIS AND RHEUMATISM
- A key role for lung-resident memory lymphocytes in protective immune responses after BCG vaccination
- (2010) Lisa M. Connor et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Mycobacterium bovis BCG-Specific Th17 Cells Confer Partial Protection against Mycobacterium tuberculosis Infection in the Absence of Gamma Interferon
- (2010) T. M. Wozniak et al. INFECTION AND IMMUNITY
- Pathological role of interleukin 17 in mice subjected to repeated BCG vaccination after infection withMycobacterium tuberculosis
- (2010) Andrea Cruz et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Essential Role of IL-17A in the Formation of a Mycobacterial Infection-Induced Granuloma in the Lung
- (2010) Y. Okamoto Yoshida et al. JOURNAL OF IMMUNOLOGY
- The Achilles heel of BCG
- (2010) Ian M. Orme TUBERCULOSIS
- Immunogenicity of a protective whole cell mycobacterial vaccine in HIV-infected adults: A phase III study in Tanzania
- (2010) Timothy Lahey et al. VACCINE
- Modified vaccinia Ankara-expressing Ag85A, a novel tuberculosis vaccine, is safe in adolescents and children, and induces polyfunctional CD4+ T cells
- (2009) Thomas J. Scriba et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Antigen Load Governs the Differential Priming of CD8 T Cells in Response to the Bacille Calmette Guerin Vaccine or Mycobacterium tuberculosis Infection
- (2009) A. A. Ryan et al. JOURNAL OF IMMUNOLOGY
- Memory T cells in nonlymphoid tissue that provide enhanced local immunity during infection with herpes simplex virus
- (2009) Thomas Gebhardt et al. NATURE IMMUNOLOGY
- A Critical Role for CD8 T Cells in a Nonhuman Primate Model of Tuberculosis
- (2009) Crystal Y. Chen et al. PLoS Pathogens
- Vaccines: Correlates of Vaccine‐Induced Immunity
- (2008) Stanley A. Plotkin CLINICAL INFECTIOUS DISEASES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now